Respiratory Disease Testing Market Expected Analysis, Revenue, Price, Market Share, Growth Rate, Forecast Upto 2024
Date: 2019-02-13   Author: Rahul Sankrityayan  Category: #industry

Respiratory Disease Testing Market Expected Analysis, Revenue, Price, Market Share, Growth Rate, Forecast Upto 2024

Respiratory disease testing market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period.

According to the International Respiratory Societies Forum, in 2014, over 200 million people across the world had COPD and nearly 235 million people were suffering from asthma. Furthermore, over 50 million individuals struggle with occupational lung disorder every year. These factors should drive respiratory disease testing market growth. Increasing healthcare expenses and reimbursement concern may restrain the industry growth during the forecast period. Low adoption rate of portable spirometers and digital radiography can also hinder the respiratory disease testing market size.

Get Table of Content of this [email protected]  https://www.gminsights.com/request-toc/upcoming/1871

 

 

Imaging tests includes x-rays, computed tomography (CT), magnetic resonance imaging, nuclear scanning, ultrasonography, and positron emission tomography (PET) scanning. Chest x-rays provide detailed framework of the heart and major blood vessels, it can also reveal serious disorder in the lungs and chest wall.

Chest x-ray reveal chronic obstructive pulmonary disease, pneumonias, atelectasis, lung tumors and pneumothorax or pleural effusion in the pleural space. It helps doctors to determine other tests required for the diagnosis. Measurement devices include respirometers, spirometers, capnographs, pulse oximeters and peak flowmeters. Demand for pulse oximeters is rising in comparison with other devices due to precise and effective diagnosis in short time and increasing adoption for these testing devices by physicians.

Hospitals contributed for significant revenue share over the forecast timeframe. The growth is attributed to advanced disease diagnostic equipment installation such as X-ray machines and measurement devices. Furthermore, increased patient visit will drive the segment growth. Diagnostic laboratories and clinics are profitable segments due to their increased demand for appropriate testing procedure and fast results.  

 By Region

U.S. respiratory disease testing market contributed for significant growth over the forecast period. The growth is attributed due to growing prevalence of respiratory diseases coupled with increasing geriatric population base. Moreover, presence of advanced healthcare system and robust distribution channel for diagnostic devices should drive industry growth. Advanced healthcare infrastructure, increased healthcare expenditure, and favourable reimbursement policies will boost Canada respiratory disease testing market share.

Germany will experience significant growth over the forecast period. The growth is attributed to growing demand for highly innovative technologies and devices. The German Center for Lung Research is an association of non-university and university institutes all over the Germany that are engaged in lung research. The purpose of the association is to develop innovative disease-specific diagnostic therapies. 

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/respiratory-disease-testing-market

By Industry

Companies operating in respiratory disease testing market includes Becton Dickinson, Koninklijke Philips, ResMed Company, Fischer & Paykel, GE Healthcare, Medtronic, Nihon Kohden Corporation, MGC Diagnostics and CAREstream Medical. Companies are mainly focusing on new product launch and merger & acquisition strategy to gain revenue. For instance, in May 2017, Philips acquired RespirTech. The RespirTech clinical support program will strengthen Philips aim to offer cost-effective and clinically focused services. 



About Author


Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for AlgosOnline, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in t...

Read More

More from Rahul


Post Recommendents

Pharmaceutical Filtration Market Competitive Analysis and Growth Projection from 2019 to 2024
Author: Rahul Sankrityayan

Pharmaceutical filtration market size should experience robust growth due to rapidly growing biopharmaceutical industry. Increasing prevalence of chronic diseases such as diabetes, cardiac disorders, cancer, and arthritis have surge in demand for ...


Mechanical Ventilator Market Analysis by Application, Types, Region and Business Growth Drivers by 2024
Author: Rahul Sankrityayan

Mechanical ventilator market size should witness significant growth due to increased prevalence of respiratory disorders over the past two decades. Mechanical ventilator is a life support system that helps patients breathe when they are unable to ...


Allergy Diagnostics Market Competitive Analysis and Growth Projection from 2019 to 2024
Author: Rahul Sankrityayan

Allergic conditions such as rhinitis or hay fever, asthma, atopic dermatitis or eczema, urticaria, sinusitis, conjunctivitis and angioedema. According to CDC, more than 50 million individuals are diagnosed with allergies in the U.S. resulting it t...